Intuitive Surgical, Inc. (NASDAQ: ISRG) reported Q2 adjusted EPS of $3.73, $0.91 better than the analyst estimate of $2.82. Revenue for the quarter came in at $512 million versus the consensus estimate of $502.23 million.

• The Company launched the da Vinci Xi system in the U.S. Fifty of the ninety-six systems shipped in the quarter were da Vinci Xi models.
• The Company entered into an agreement with its Japanese distributor to transition the business to a direct market in June.
• The Company's vessel sealer was cleared by the FDA for use with da Vinci Xi.
• The Company received FDA clearance of da Vinci SP 999 and commenced efforts to develop the product towards commercialization.

For earnings history and earnings-related data on Intuitive Surgical, Inc. (ISRG) click here.